Navigation Links
Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - Elixir Pharmaceuticals, Inc., announced today new preclinical data confirming ghrelin antagonism as a potential method for regulating metabolism, decreasing body weight and managing blood glucose. The data were presented in poster sessions during ENDO 07, The Endocrine Society's 89th Annual Meeting, being held in Toronto, Canada. Elixir is focused on the development of drugs to treat and prevent metabolic disease, as well as prevent age-related diseases, based on targets identified in the pathways regulating aging.

Ghrelin is a key metabolic regulator that is known to stimulate appetite and food consumption and is believed to play a key role in metabolism and energy storage. Ghrelin is a naturally occurring hormone secreted by the stomach, which acts primarily at the level of the hypothalamus in the brain.

In the first presentation, Elixir scientists explored whether ghrelin exerts a direct effect on adipocytes (fat cells) and if the effect is mediated through ghrelin receptor (GhrR) mRNA expression in these cells. To assess this, the scientists first examined ghrelin signaling by measuring insulin sensitivity in mouse adipocyte cell lines that were treated with ghrelin for four days. Scientists also assessed the expression of GhrR mRNA in adipose tissue, isolated adipocytes from mice, and the mouse adipocyte cell-line. The results showed GhrR was detected in the isolated adipocytes and mouse adipocyte cell lines, suggesting ghrelin acts directly through its receptor on adipocytes to regulate energy homeostasis. Moreover, the reduction of insulin signaling in adipocytes by chronic ghrelin treatment provides a possible mechanism for increased insulin sensitivity in GhrR knockout mice.

In two additional tandem presentations, Elixir scientists showed that, compared to control mice, GhrR knockout mice resisted the development of diabetes and obesity ass
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
2. Elixir Pharmaceuticals Announces Clinical Data at American Diabetes Association Conference Highlighting Ability of Glufast to Maintain Glycemic Control in Patients with Type 2 Diabetes
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
(Date:5/21/2013)... , May 21, 2013 New ... the American Psychiatric Association show that the NeuroStar ... clinically meaningful response and remission in patients with ... of therapy, which were maintained through one year ... 62 percent of patients achieved symptomatic improvement while ...
(Date:5/21/2013)... May 21, 2013   Regulus Therapeutics Inc . ... discovery and development of innovative medicines targeting microRNAs, today ... Ph.D., Chief Operating Officer and Executive Vice President, Finance, ... 38th Annual Healthcare Conference on Wednesday, May 29, 2013 ... at the Westin Boston Waterfront Hotel. The ...
Breaking Medicine Technology:Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2
... Athersys, Inc. (Nasdaq: ATHX ) today announced ... at Retail Investor Confrences.com. DATE: , January 11, 2011TIME: ... be a live, interactive online event where investors are invited ... presentation hall as well as the company,s "virtual trade booth." ...
... Technology, a leading provider of advanced computer assisted ... commercial installation of its IQQA®-Liver Enterprise product at ... of the top performing living donor liver transplantation ... EDDA Technology,s IQQA®-Liver Enterprise in conjunction with its ...
Cached Medicine Technology:Athersys to Present Live at Retail Investor Conferences.com on January 11th 2EDDA Technology Successfully Installs IQQA®-Liver at Mayo Clinic in Arizona 2
(Date:5/22/2013)... 2013 Seva Call (Save-A-Call) has launched ... businesses and connects consumers to the right available professional ... time to handle personal matters than the national and ... from work. So, they really can’t afford the 30 ... available professional. , Now, Detroit residents will be able ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Following ... the fitness franchise Fit Body Boot Camp ... Annual 1,000 lb. Meltdown Challenge starting on June 3rd ... Davidson Centre 601 Durham Street, Kincardine, Ontario.     , Fit ... to inspire and motivate local community residents to lose ...
(Date:5/22/2013)... May 22, 2013 Hypervibe, a leader ... , announced today that the company’s US division will ... and Monday. Military personnel ordering the Hypervibe Performance during ... they show a valid military ID. Non-military customers receive ... values commitment, honor, and integrity. These are values that ...
(Date:5/22/2013)... 2013 Asthma, a disorder that causes ... causes wheezing, shortness of breath, chest tightness and coughing ... muscles surrounding the airways become tight and the lining ... air that can pass. Asthma attacks can last for ... severely restricted. Reuters reports that there is ...
(Date:5/22/2013)... 22, 2013 Patients with type 1 ... have better glycemic control as measured by significantly lower ... condition with insulin injections, according to new findings from ... conducted by Kantar Health . The research was ... (International Society for Pharmacoeconomics and Outcomes Research) in New ...
Breaking Medicine News(10 mins):Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:Hypervibe Whole Body Vibration Offers First-Ever Sale This Memorial Day Weekend 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research 2Health News:Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research 3
... is,pursuing its external growth strategy in Italy and the ... development in Italy with the acquisition,of Galileo, a major ... stock lenses under its own brand, which is widely,recognized ... a prescription laboratory in Milan and generates EUR13 million ...
... between father,s, but not mother,s, weight and elevated enzymes ... fathers had early-onset obesity are at increased risk for ... U.S. study. , Researchers evaluated 1,732 children, average age ... long-term study of families in Framingham, Mass. The researchers ...
... 2008 PAHEF is,pleased to join Harvard University,s ... partner in the bi-annual conference,Frontiers of Innovation: 20 ... 31st through today. On Monday evening, the executive,director ... (PAHEF), Mr.,Edward Kadunc, discussed multisector partnerships in tackling ...
... reducing food intake 30% decreased infection-fighting cells , , THURSDAY, April ... remember whether it,s "starve a cold, feed a fever" or ... , A study of deer mice has found that reducing ... system. The findings are published in the May/June issue of ...
... the Stars, The View Hosts Agree: March of Dimes,Fund-raising Walk ... 2008 It doesn,t,matter what you call it, March of ... Babies(SM) will be held the last weekend in April in ... their support to the March of,Dimes work to help moms ...
... Fifth Third Bank,today announced a strategic alliance with ... revenue cycle management services to,the healthcare industry, that ... for healthcare providers. The alliance,will enable Fifth Third ... from,claims to payments -- and integrate the data ...
Cached Medicine News:Health News:Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States 2Health News:Dads' Early-Onset Obesity Linked to Liver Disease in Kids 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2Health News:Eating Less May Hinder Immune System 2Health News:March For Babies Has Celebrity Support -- Now It Needs Yours 2Health News:Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform 2Health News:Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform 3
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Stab Blade Knife, 45 blade. Blade tip dimension: 8.9 mm x 1.9 mm x 1.9 mm....
Full Handle Laseredge Stab Blade Knife, 15 blade. Blade tip dimension: 11.1 mm x 1.5 mm x 5.7 mm....
Medicine Products: